{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:46:30Z","timestamp":1772196390005,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.018","type":"journal-article","created":{"date-parts":[[2010,12,19]],"date-time":"2010-12-19T09:06:29Z","timestamp":1292749589000},"page":"1123-1125","source":"Crossref","is-referenced-by-count":4,"title":["Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine"],"prefix":"10.1016","volume":"29","author":[{"given":"Emilie","family":"Javelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Soulier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Brosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Lorcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.12.018_bib0005","first-page":"249","article-title":"New influenza A (H1N1) virus: global epidemiological situation, June 2009","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0010","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.vaccine.2009.12.014","article-title":"Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer blind, randomised trial","volume":"28","author":"Roman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0015","unstructured":"CHMP Assessment Report for Pandemrix (EMEA\/CHMP\/619109\/2009). European Medicines Agency, September 2009 at http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/000832\/WC500095422.pdf."},{"key":"10.1016\/j.vaccine.2010.12.018_bib0020","unstructured":"Bilan actualis\u00e9 de pharmacovigilance des vaccins antigrippaux A\/H1N1. Agence Fran\u00e7aise de S\u00e9curit\u00e9 Sanitaire des Produits de Sant\u00e9 (AFSSAPS), May 2010 at http:\/\/www.afssaps.fr\/var\/afssaps_site\/storage\/original\/application\/e41f68fbee043b89e1fc740dac52d2e1.pdf."},{"key":"10.1016\/j.vaccine.2010.12.018_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/375820","article-title":"Extensive limb swelling after immunization: reports to the vaccine adverse event reporting system","volume":"37","author":"Woo","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2010.12.018_bib0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiol.2402050405","article-title":"Parsonage-Turner syndrome MR imaging findings and clinical information of 27 patients","volume":"240","author":"Gaskin","year":"2006","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.018_bib0035","first-page":"13","article-title":"Polymyositis: rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome","volume":"95","author":"Ram\u00edrez-Rivera","year":"2003","journal-title":"Bol Asoc Med P R"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.018_bib0040","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/0883073807312370","article-title":"Macrophagic myofasciitis in children is a localized reaction to vaccination","volume":"23","author":"Lach","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.bjps.2006.01.018","article-title":"Morphea of the breast: two case reports and discussion of the literature","volume":"59","author":"Dancey","year":"2006","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0050","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000141959","article-title":"Primary atrophic solitary morphea profunda","volume":"217","author":"Khelifa","year":"2008","journal-title":"Dermatology"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0055","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2009-2773","article-title":"Lipoatrophy induced by subcutaneous insulin infusion: ultrastructural analysis and gene expression profiling","author":"Milan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0190-9622(96)90673-8","article-title":"Localized involutional lipoatrophy: a clinicopathologic study of 16 patients","volume":"35","author":"Dahl","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1440-0960.2006.00291.x","article-title":"Leg crossers\u2019 dimple: a form of localised lipoatrophy","volume":"47","author":"Kalouche","year":"2006","journal-title":"Aust J Dermatol"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0070","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1365-4632.2007.03268.x","article-title":"DTP vaccine-induced lipoatrophy: an observational study","volume":"46","author":"Sardana","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0075","first-page":"335","article-title":"Local subcutaneous atrophy following measles, mumps and rubella vaccination","volume":"130","author":"Buntain","year":"1976","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0080","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1016\/j.vaccine.2009.06.026","article-title":"Quadrivalent human papillomavirus recombinant vaccine associated lipoatrophy","volume":"27","author":"Ojaimi","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2010.12.018_bib0085","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000372-200608000-00008","article-title":"Post-injection involutional lipoatrophy: ultrastructural evidence for an activated macrophage phenotype and macrophage related involution of adipocytes","volume":"28","author":"Ahmed","year":"2006","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.vaccine.2010.12.018_bib0090","first-page":"495","article-title":"Complications dermatologiques li\u00e9es \u00e0 la vaccination anti-h\u00e9patite B","volume":"34","author":"Aubin","year":"1994","journal-title":"Rev Fr Allergol Immunol"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0095","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors","volume":"275","author":"Dowell","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0100","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1542\/peds.2008-0374","article-title":"Optimal intramuscular needle-penetration depth","volume":"122","author":"Lippert","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.12.018_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0264-410X(00)00171-7","article-title":"Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults","volume":"19","author":"Boyce","year":"2000","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T05:26:04Z","timestamp":1544073964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10017561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10017561"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}